NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Cognizant Technology Solutions Corporation (NASDAQ:CTSH), OPKO Health, Inc. (NASDAQ:OPK), MedEquities Realty Trust Inc. (NYSE:MRT), AXT Inc (NASDAQ:AXTI), Red Robin Gourmet Burgers, Inc. (NASDAQ:RRGB), and Dorian LPG Ltd. (NYSE:LPG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CTSH DOWNLOAD: http://Capital-Review.com/register/?so=CTSH
OPK DOWNLOAD: http://Capital-Review.com/register/?so=OPK
MRT DOWNLOAD: http://Capital-Review.com/register/?so=MRT
AXTI DOWNLOAD: http://Capital-Review.com/register/?so=AXTI
RRGB DOWNLOAD: http://Capital-Review.com/register/?so=RRGB
LPG DOWNLOAD: http://Capital-Review.com/register/?so=LPG

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Cognizant Technology Solutions Corporation (NASDAQ:CTSH), OPKO Health, Inc. (NASDAQ:OPK), MedEquities Realty Trust Inc. (NYSE:MRT), AXT Inc (NASDAQ:AXTI), Red Robin Gourmet Burgers, Inc. (NASDAQ:RRGB), and Dorian LPG Ltd. (NYSE:LPG) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 11th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION (CTSH) REPORT OVERVIEW

Cognizant Technology Solutions' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cognizant Technology Solutions reported revenue of $4,078.00MM vs $3,766.00MM (up 8.28%) and analysts estimated basic earnings per share $0.82 vs $0.84 (down 2.38%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cognizant Technology Solutions reported revenue of $14,810.00MM vs $13,487.00MM (up 9.81%) and analysts estimated basic earnings per share $2.54 vs $2.56 (down 0.78%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.99. The estimated EPS forecast for the next fiscal year is $4.92 and is expected to report on February 5th, 2020.

To read the full Cognizant Technology Solutions Corporation (CTSH) report, download it here: http://Capital-Review.com/register/?so=CTSH

-----------------------------------------

OPKO HEALTH, INC. (OPK) REPORT OVERVIEW

OPKO Health's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, OPKO Health reported revenue of $249.82MM vs $246.04MM (up 1.53%) and analysts estimated basic earnings per share -$0.05 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, OPKO Health reported revenue of $1,067.50MM vs $1,221.66MM (down 12.62%) and analysts estimated basic earnings per share -$0.55 vs -$0.05. Analysts expect earnings to be released on March 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is -$0.19 and is expected to report on March 7th, 2019.

To read the full OPKO Health, Inc. (OPK) report, download it here: http://Capital-Review.com/register/?so=OPK

-----------------------------------------

MEDEQUITIES REALTY TRUST INC. (MRT) REPORT OVERVIEW

MedEquities Realty Trust's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, MedEquities Realty Trust reported revenue of $9.68MM vs $15.77MM (down 38.61%) and analysts estimated basic earnings per share -$0.07 vs $0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, MedEquities Realty Trust reported revenue of $61.11MM vs $49.30MM (up 23.96%) and analysts estimated basic earnings per share $0.64 vs -$0.18. Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on February 20th, 2019.

To read the full MedEquities Realty Trust Inc. (MRT) report, download it here: http://Capital-Review.com/register/?so=MRT

-----------------------------------------

AXT INC (AXTI) REPORT OVERVIEW

AXT's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, AXT reported revenue of $28.63MM vs $28.17MM (up 1.63%) and basic earnings per share $0.10 vs $0.11 (down 9.09%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, AXT reported revenue of $98.67MM vs $81.35MM (up 21.30%) and analysts estimated basic earnings per share $0.27 vs $0.17 (up 58.82%). Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $0.30 and is expected to report on February 20th, 2019.

To read the full AXT Inc (AXTI) report, download it here: http://Capital-Review.com/register/?so=AXTI

-----------------------------------------

RED ROBIN GOURMET BURGERS, INC. (RRGB) REPORT OVERVIEW

Red Robin Gourmet Burgers' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Red Robin Gourmet Burgers reported revenue of $294.88MM vs $305.70MM (down 3.54%) and analysts estimated basic earnings per share $0.13 vs $0.21 (down 38.10%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Red Robin Gourmet Burgers reported revenue of $1,380.93MM vs $1,296.44MM (up 6.52%) and analysts estimated basic earnings per share $2.33 vs $0.88 (up 164.77%). Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.78. The estimated EPS forecast for the next fiscal year is $1.71 and is expected to report on February 28th, 2019.

To read the full Red Robin Gourmet Burgers, Inc. (RRGB) report, download it here: http://Capital-Review.com/register/?so=RRGB

-----------------------------------------

DORIAN LPG LTD. (LPG) REPORT OVERVIEW

Dorian LPG's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Dorian LPG reported revenue of $55.11MM vs $44.55MM (up 23.72%) and analysts estimated basic earnings per share -$0.11 vs $0.03. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Dorian LPG reported revenue of $159.33MM vs $167.45MM (down 4.84%) and analysts estimated basic earnings per share -$0.38 vs -$0.03. Analysts expect earnings to be released on June 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.09 and is expected to report on June 21st, 2019.

To read the full Dorian LPG Ltd. (LPG) report, download it here: http://Capital-Review.com/register/?so=LPG

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Nicole Garrens, Media Department
Office: +1 (410) 280-7496
E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.